The editorial boards, staff, and editors-in-chief of The Journal of Immunology and ImmunoHorizons, first and foremost, extend their sincere wishes for your safety, and the safety of your families and professional communities. We recognize how challenging these times are as we all navigate the burdens imposed by the COVID-19 pandemic. We appreciate, also, that these are trying times in which to keep research moving ahead.
For our authors with manuscripts under revision, we recognize that lab closures may be disruptive and limit your ability to respond to reviewer comments. You may wish to contact your editor to discuss which revisions can be accomplished during lab closures. Editors will prioritize reviewer comments to reduce the need for additional experiments, if possible, and still preserve the scientific integrity of the work. To address concerns about prioritizing the most important reviewer comments, please send an email to InfoJI@aai.org or InfoIH@aai.org. Your message will be forwarded to the appropriate editor.
For our reviewers, we understand that there may be delays in returning a review. If you need more time to complete a review, or need to decline an assignment, please contact the AAI editorial office as soon as possible at the email addresses listed above.
The staff that support The JI and IH are available and stand ready to assist you in any way possible. Please contact us at the email addresses above.
We salute the thousands of dedicated scientists who continue to pursue their research and assist with the peer review process even in the most challenging of times. We are especially grateful to our research community members who are on the frontlines of this pandemic serving the needs of patients. From all of us at The American Association of Immunologists, thank you.
_____
AAI Establishes COVID-19 Resource Center
AAI has established a resource center for members that contains resources, information, and news related to the coronavirus pandemic.
Visit https://www.aai.org/COVID-19-Resources now.